Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GSPT1, also known as eukaryotic peptide chain release factor GTP-binding subunit ERF3A (eRF3a), is a GTPase that plays a critical role in translation termination during protein synthesis. It functions as part of the eRF1-eRF3-GTP ternary complex, which mediates translation termination at stop codons on mRNA. Targeting its degradation via cereblon modulators shows promise for treating hematologic malignancies.
Cereblon-dependent ubiquitination and degradation of GSPT1 via the CRL4(CRBN) E3 ubiquitin ligase pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTP-binding protein GSPT1 (G1 to S phase transition 1) (GSPT1).